Regulatory Perspectives on clinical Trials Endpoints

First Page		Document Content
Date: 2009-01-05 11:05:13 Combination drugs Asthma Salmeterol Formoterol Fluticasone/salmeterol Long-acting beta-adrenoceptor agonist Bronchodilator Budesonide/formoterol Mometasone/formoterol Pulmonology Medicine Respiratory therapy		Regulatory Perspectives on clinical Trials Endpoints Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 84,45 KB Share Document on Facebook

	As at AugustAstraZeneca’s Environmental Risk Summaries As part of AstraZeneca’s ongoing commitment to environmental data transparency, this website provides environmental risk summaries for the Active Pharmace DocID: 1rlq4 - View Document
	Microsoft Word - Prosonix full abstract for DDL22_2_.doc DocID: 1rcKt - View Document
	Preferred Drug List Blue Cross complete DocID: 1pc13 - View Document
	Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MATelNews Release Contact: DocID: 1pbCs - View Document
	Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth DocID: 1oNoo - View Document